245 related articles for article (PubMed ID: 32779806)
21. Polypharmacy management among Australian veterans: improving prescribing through the Australian Department of Veterans' Affairs' prescriber feedback programme.
Woodward MC; Streeton CL; Guttmann A; Killer GT; Peck RW
Intern Med J; 2008 Feb; 38(2):95-100. PubMed ID: 18005132
[TBL] [Abstract][Full Text] [Related]
22. Trends in opioid prescribing in Australia: a systematic review.
Donovan PJ; Arroyo D; Pattullo C; Bell A
Aust Health Rev; 2020 Apr; 44(2):277-287. PubMed ID: 32241339
[TBL] [Abstract][Full Text] [Related]
23. Psychotropic and other medicine use at time of death by suicide: a population-level analysis of linked dispensing and forensic toxicology data.
Chitty KM; Buckley NA; Lim J; Ali Z; Schumann JL; Cairns R; Daniels B; Pearson SA; Preen DB; Schaffer AL
Med J Aust; 2023 Jul; 219(2):63-69. PubMed ID: 37230472
[TBL] [Abstract][Full Text] [Related]
24. Choosing wisely? Quantifying the extent of three low value psychotropic prescribing practices in Australia.
Brett J; Zoega H; Buckley NA; Daniels BJ; Elshaug AG; Pearson SA
BMC Health Serv Res; 2018 Dec; 18(1):1009. PubMed ID: 30594192
[TBL] [Abstract][Full Text] [Related]
25. A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy.
Brett J; Pearson SA; Daniels B; Wylie CE; Buckley NA
Br J Clin Pharmacol; 2021 Mar; 87(3):1369-1377. PubMed ID: 32881057
[TBL] [Abstract][Full Text] [Related]
26. Non-prescription medicines may contribute to non-adherence to prescription medicines in people living with chronic health conditions.
Anoopkumar-Dukie S; Mey A; Hall S; Bernaitis N; Davey AK; Plummer D
Int J Clin Pract; 2020 Jun; 74(6):e13489. PubMed ID: 32083362
[TBL] [Abstract][Full Text] [Related]
27. Antipsychotic polypharmacy in older Australians.
Kalisch Ellett LM; Pratt NL; Kerr M; Roughead EE
Int Psychogeriatr; 2018 Apr; 30(4):539-546. PubMed ID: 29122047
[TBL] [Abstract][Full Text] [Related]
28. GP-Led Deprescribing in Community-Living Older Australians: An Exploratory Controlled Trial.
Anderson K; Freeman C; Foster M; Scott I
J Am Geriatr Soc; 2020 Feb; 68(2):403-410. PubMed ID: 31792947
[TBL] [Abstract][Full Text] [Related]
29. The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers.
Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA
BMC Res Notes; 2015 Nov; 8():634. PubMed ID: 26526064
[TBL] [Abstract][Full Text] [Related]
30. Progressivity of out-of-pocket costs under Australia's universal health care system: A national linked data study.
Law HD; Marasinghe D; Butler D; Welsh J; Lancsar E; Banks E; Biddle N; Korda R
Health Policy; 2023 Jan; 127():44-50. PubMed ID: 36456400
[TBL] [Abstract][Full Text] [Related]
31. Anticholinergic medicines use among older adults before and after initiating dementia medicines.
Narayan SW; Pearson SA; Litchfield M; Le Couteur DG; Buckley N; McLachlan AJ; Zoega H
Br J Clin Pharmacol; 2019 Sep; 85(9):1957-1963. PubMed ID: 31046175
[TBL] [Abstract][Full Text] [Related]
32. Moral hazard and prescription medicine use in Australia--the patient perspective.
Doran E; Robertson J; Henry D
Soc Sci Med; 2005 Apr; 60(7):1437-43. PubMed ID: 15652677
[TBL] [Abstract][Full Text] [Related]
33. Characterising polypharmacy in the very old: Findings from the Newcastle 85+ Study.
Davies LE; Kingston A; Todd A; Hanratty B
PLoS One; 2021; 16(1):e0245648. PubMed ID: 33465141
[TBL] [Abstract][Full Text] [Related]
34. Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation.
Islam MM; McRae IS; Mazumdar S; Simpson P; Wollersheim D; Fatema K; Butler T
BMC Pharmacol Toxicol; 2018 Jun; 19(1):30. PubMed ID: 29914572
[TBL] [Abstract][Full Text] [Related]
35. Assessment of medicines use pattern using World Health Organization's Prescribing, Patient Care and Health facility indicators in selected health facilities in eastern Ethiopia.
Bilal AI; Osman ED; Mulugeta A
BMC Health Serv Res; 2016 Apr; 16():144. PubMed ID: 27106610
[TBL] [Abstract][Full Text] [Related]
36. Medicine reviews: do they reduce benzodiazepine use in older Australians?
Coleman LA; Brett J; Daniels BJ; Falster MO
Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494072
[TBL] [Abstract][Full Text] [Related]
37. Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians.
Kouladjian O'Donnell L; Reeve E; Cumming A; Scott IA; Hilmer SN
Intern Med J; 2021 Jan; 51(1):111-115. PubMed ID: 33572018
[TBL] [Abstract][Full Text] [Related]
38. Drug utilization among hypertensive patients in the outpatient department of medicine in a tertiary care hospital: A cross-sectional study.
Paradkar SG; Sinha SR
Clin Exp Hypertens; 2018; 40(2):150-154. PubMed ID: 28816547
[TBL] [Abstract][Full Text] [Related]
39. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013.
Nishtala PS; Salahudeen MS
Gerontology; 2015; 61(3):195-202. PubMed ID: 25428287
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and predictors of polypharmacy among older primary care patients in Germany.
Junius-Walker U; Theile G; Hummers-Pradier E
Fam Pract; 2007 Feb; 24(1):14-9. PubMed ID: 17164234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
